A video series with continuing education for naturopathic physicians, bringing together ten recordings in one discounted package
Note: The information in this series is provided as a research resource for health professionals and is not intended to replace diagnosis and treatment by a qualified health care practitioner.
This 2026 Pharmacy Video Series brings together ten clinically focused presentations exploring the intersection of botanical medicine, pharmacology and integrative patient care. The series covers medication and botanical safety, neurological and autoimmune conditions, oncology, opioid cessation, heavy-metal chelation, hormones, and men's health.
All lectures were recorded at our 2026 Conferences and are now available on-demand with CE credit.
Donald Yance begins with Phytoestrogens – What are They and What's all the Fuss? Yance examines how phytoestrogens interact with estrogen signaling and challenges the assumption that all estrogenic activity should be viewed alike. The presentation considers tissue-specific effects, mechanisms, clinical implications and the evidence surrounding phytoestrogen use. (26ME05)
Kenneth Proefrock, NMD, presents Clinical Updates in the Naturopathic Treatment of Seizure Disorders, Epilepsy, Tremors and Neuropathies. He explores neurological conditions through a naturopathic clinical lens, including treatment considerations relevant to patients using conventional medications alongside botanical and nutritional interventions. (26ME12)
Donald Yance, CN, RH (AHG), opens a direct discussion of botanical and pharmaceutical safety in Herb-Drug Interactions: A Systems-Based Approach to Safety. Rather than treating interactions simply as lists of contraindications, Yance examines them in the broader context of pharmacokinetics, pharmacodynamics, patient physiology and the clinical circumstances in which herbs and medications are being combined. (26ME19)
Lise Alschuler, ND, FABNO, eMBA, presents Addressing the Cancer Terrain with Botanicals. This evidence-informed oncology lecture examines the tumor microenvironment, metabolic drivers of cancer and botanical strategies targeting processes including inflammation, insulin resistance, mitochondrial dysfunction and cellular signaling. Her material includes comparisons such as berberine and metformin and discusses medications among potential contributors to mitochondrial damage. (26SW01)
Marianne Marchese, ND, examines both botanical and pharmaceutical approaches in Heavy Metal Exposure and Using Botanicals and Pharmaceutical Chelation. The lecture addresses assessment and treatment of heavy-metal exposure and compares botanical strategies with pharmaceutical chelating agents. (26SW09)
Mary Rondeau, ND, RH (AHG), and Suzanne Blaising, PhD, present Bridging Worlds: Psilocybin, Plant Allies, and the Art of Psychedelic Healing.The presentation explores psilocybin and plant allies within psychedelic healing, with attention to clinical integration and the therapeutic context surrounding psychedelic medicine. (26SW15)
Jen Stovall, BSN, RN, presents Holding the Middle: Herbal Approaches to Opioid Cessation. This presentation explores botanical support during opioid cessation and recovery, with attention to the physiological challenges of withdrawal and the role herbs can play within a broader approach to patient support. (26SW18)
Christina Veselak, LMFT, CN, presents Bio-nutritional & Herbal Foundations of Addiction.Veselak explores addiction through the lens of brain chemistry and nutritional status, examining how imbalances in neurotransmitters and blood sugar can contribute to cravings, mood symptoms and relapse. She outlines a biochemical approach to recovery using targeted nutrition, amino acids and herbal support to help stabilize brain function and support long-term recovery. (26SW19)
Wendy Warner, MD, ABIHM, IFMCP, presents Modulating Immune Response: Nutritional and Botanical Therapies for Autoimmune Issues. Warner examines nutritional and botanical approaches to immune dysregulation and their application in patients with autoimmune conditions, adding an immune-focused clinical perspective to the series. (26SW20)
Eric Yarnell, ND, RH (AHG), Katie Stage, ND, RH (AHG), FABNG, and Donald Yance, CN, RH (AHG), come together for Panel: Optimizing Men's Health: Integrative Strategies for Body, Mind & Beyond. The panel draws on several clinical perspectives to examine integrative approaches to men's health and the intersection of botanical, nutritional and conventional care. (26SW22)
CNDA:Approved for up to 15 CE hours: 4.5 general + 10.5 pharmacy.
SUHS:Approved for up to 15 CE hours: 4.5 general + 10.5 pharamcy (or 3 opioid + 7.5 pharmacy).
| CE Code | Lecture Title | Speaker(s) | General Hours | Pharmacy Hours |
| 26ME05 | Phytoestrogens – What are They and What's all the Fuss | Donnie Yance, CN, RH (AHG) | 0.5 | 1 |
| 26ME12 | Clinical Updates in the Naturopathic Treatment of Seizure Disorders, Epilepsy, Tremors and Neuropathies | Kenneth Proefrock, NMD | 0.5 | 1 |
| 26ME19 | Herb-Drug Interactions: A Systems-Based Approach to Safety |
Donnie Yance, CN, RH (AHG)
|
1.5 | |
| 26SW01 | Addressing the Cancer Terrain with Botanicals | Lise Alschuler, ND, FABNO, eMBA | 1 | 0.5 |
| 26SW09 | Heavy Metal Exposure and Using Botanicals and Pharmaceutical Chelation | Marianne Marchese, ND | 0.5 | 1 |
| 26SW15 | Bridging Worlds: Psilocybin, Plant Allies, and the Art of Psychedelic Healing, Part 2 | Mary Rondeau, ND, RH (AHG) & Suzanne Blaising, PhD | 0.5 | 1 |
| 26SW18 | Holding the Middle: Herbal Approaches to Opioid Cessation |
Jen Stovall, BSN, RN
|
1.5 (or 1.5 opioid) |
|
| 26SW19 | Bio-nutritional & Herbal Foundations of Addiction and Recovery |
Christina Veselak, LMFT, CN
|
1.5 (or 1.5 opioid) |
|
| 26SW20 | Nutritional/Botanical Therapies for Autoimmune Issues | Wendy Warner, MD, ABIHM, IFMCP | 1 | 0.5 |
| 26SW22 | Panel: Optimizing Men's Health: Integrative Strategies for Body, Mind & Beyond | Eric Yarnell, ND, RH (AHG); Katie Stage, ND, RH (AHG), FABNG; Donald Yance, CN, RH (AHG) | 0.5 | 1 |
| TOTAL | 4.5 | 10.5 |